Evidence map›Paper›PMID 27535281›Full record

ArticleDiabetologia2016

The epigenetic signature of systemic insulin resistance in obese women.

Peter Arner, Anna-Stina Sahlqvist, Indranil Sinha, Huan Xu, Xiang Yao, Dawn Waterworth, Deepak Rajpal, A Katrina Loomis, Johannes M Freudenberg, Toby Johnson and 4 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 55 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 2 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 3 countries.

Peter ArnerDepartment of Medicine, Karolinska Institutet, Karolinska University Hospital, C2:94, Huddinge, S-141 86, Stockholm, Sweden.
Anna-Stina SahlqvistGlaxoSmithKline R&D, Stevenage, UK.
Indranil SinhaDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Huan XuGlaxoSmithKline R&D, Research Triangle Park, NC, USA.
Xiang YaoComputational and Systems Biology, Discovery Sciences, Janssen Pharmaceutical, Research & Development, LLC, San Diego, CA, USA.
Dawn WaterworthGlaxoSmithKline R&D, King of Prussia, PA, USA.
Deepak RajpalGlaxoSmithKline R&D, King of Prussia, PA, USA.
A Katrina LoomisPfizer Worldwide Research and Development, Groton, CT, USA.
Johannes M FreudenbergGlaxoSmithKline R&D, King of Prussia, PA, USA.
Toby JohnsonGlaxoSmithKline R&D, Stevenage, UK.
Anders ThorellDepartment of Surgery, Ersta Hospital, Stockholm, Sweden.
Erik NäslundDepartment of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden.
Mikael RydenDepartment of Medicine, Karolinska Institutet, Karolinska University Hospital, C2:94, Huddinge, S-141 86, Stockholm, Sweden.
Ingrid DahlmanDepartment of Medicine, Karolinska Institutet, Karolinska University Hospital, C2:94, Huddinge, S-141 86, Stockholm, Sweden. ingrid.dahlman@ki.se.
GlaxoSmithKline (United States) · USKarolinska Institutet · SEAge UK · GBErsta sjukhus · SEGlaxoSmithKline (United Kingdom) · GBJanssen (United States) · USKarolinska University Hospital · SEPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisInsulin resistance (IR) links obesity to type 2 diabetes. The aim of this study was to explore whether white adipose tissue (WAT) epigenetic dysregulation is associated with systemic IR by genome-wide CG dinucleotide (CpG) methylation and gene expression profiling in WAT from insulin-resistant and insulin-sensitive women. A secondary aim was to determine whether the DNA methylation signature in peripheral blood mononuclear cells (PBMCs) reflects WAT methylation and, if so, can be used as a marker for systemic IR.

methodsFrom 220 obese women, we selected a total of 80 individuals from either of the extreme ends of the distribution curve of HOMA-IR, an indirect measure of systemic insulin sensitivity. Genome-wide transcriptome and DNA CpG methylation profiling by array was performed on subcutaneous (SAT) and visceral (omental) adipose tissue (VAT). CpG methylation in PBMCs was assayed in the same cohort.

resultsThere were 647 differentially expressed genes (false discovery rate [FDR] 10%) in SAT, all of which displayed directionally consistent associations in VAT. This suggests that IR is associated with dysregulated expression of a common set of genes in SAT and VAT. The average degree of DNA methylation did not differ between the insulin-resistant and insulin-sensitive group in any of the analysed tissues/cells. There were 223 IR-associated genes in SAT containing a total of 336 nominally significant differentially methylated sites (DMS). The 223 IR-associated genes were over-represented in pathways related to integrin cell surface interactions and insulin signalling and included COL5A1, GAB1, IRS2, PFKFB3 and PTPRJ. In VAT there were a total of 51 differentially expressed genes (FDR 10%); 18 IR-associated genes contained a total of 29 DMS. CONCLUSIONS/

interpretationIn individuals discordant for insulin sensitivity, the average DNA CpG methylation in SAT and VAT is similar, although specific genes, particularly in SAT, display significantly altered expression and DMS in IR, possibly indicating that epigenetic regulation of these genes influences metabolism.

Indexed as

Adaptor Proteins, Signal TransducingAdipose Tissue, WhiteAdultCollagen Type VDNA MethylationEpigenesis, GeneticFemaleHumansInsulin Receptor Substrate ProteinsInsulin ResistanceIntra-Abdominal FatLeukocytes, MononuclearObesityPhosphofructokinase-2Receptor-Like Protein Tyrosine Phosphatases, Class 3Signal TransductionAdaptor Proteins, Signal TransducingCOL5A1 protein, humanCollagen Type VGAB1 protein, humanInsulin Receptor Substrate ProteinsIRS2 protein, humanPFKFB3 protein, humanPhosphofructokinase-2PTPRJ protein, humanReceptor-Like Protein Tyrosine Phosphatases, Class 3CpG islandDNA methylationVisceral adipose tissue

Identifiers

PMID27535281
PMCPMC5506095
OpenAlexW2514674853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.